Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/33151
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHorowitz, M.en
dc.contributor.authorFeinle-Bisset, C.en
dc.contributor.authorJones, K.en
dc.contributor.authorNauck, M.en
dc.date.issued2004en
dc.identifier.citationDiabetes Care, 2004; 27(11):2770en
dc.identifier.issn0149-5992en
dc.identifier.issn1935-5548en
dc.identifier.urihttp://hdl.handle.net/2440/33151-
dc.description© 2004 by the American Diabetes Association, Inc.en
dc.description.statementofresponsibilityMichael Horowitz, Christine Feinle-Bisset, Karen Jones and Michael Naucken
dc.language.isoenen
dc.publisherAmer Diabetes Assocen
dc.subjectHumans; Diabetes Mellitus, Type 2; Obesity; Lactones; Glucagon; Peptide Fragments; Protein Precursors; Anti-Obesity Agents; Postprandial Period; Glucagon-Like Peptide 1; Orlistaten
dc.titleOrlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Damci et al.en
dc.typeJournal articleen
dc.identifier.rmid0020042661en
dc.identifier.doi10.2337/diacare.27.11.2770en
dc.identifier.pubid55380-
pubs.library.collectionMedicine publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]en
dc.identifier.orcidFeinle-Bisset, C. [0000-0001-6848-0125]en
dc.identifier.orcidJones, K. [0000-0002-1155-5816]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.